Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

AIFU vs BON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BON Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–4 Matrix Metrics)

BON Overall Winner 6-Pillar Tally: AIFU 0 – 5 BON (1 Tie) Matrix Metrics: AIFU 4 – 6 BON

As of Nov 17, 2026, Bon Natural Life Limited Class A (BON) is the stronger overall head-to-head candidate over AIFU Inc. Class A Ordinary Share (AIFU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AIFU carries a Unified Composite Score of 58.5/100 (HOLD) at $9.76 (18.8x Forward P/E, -220.0% operating margin), whereas BON carries 52.3/100 (HOLD) at $1.02 (2.4x Forward P/E, -45.5% operating margin).

  • Composite vs. Pillar Nuance: While AIFU currently prints a higher short-term Unified Composite Score (58.5/100 HOLD vs. BON 52.3/100 HOLD), BON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-45.5% vs. -220.0% operating margin) and revenue trajectory (+1.9% vs. -24.0% YoY).
  • Technical & Structure Timing Caution: AIFU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.1); meanwhile BON is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About AIFU vs BON
AIFU NASDAQ
AIFU Inc. Class A Ordinary Share
Insurance Agents, Brokers & Service
$9.76
-0.85% 1D
Market Cap $590.2M
TTM Revenue $485M
Forward P/E 18.8x
Beta / 30D Vol -7.07β · 88% Vol
Unified Composite Score
58.5 / 100 HOLD
Tech 79.0 Fund 63.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.1 · SMA20: $9.51 · SMA50: $10.40
BON NASDAQ Head-to-Head Winner
Bon Natural Life Limited Class A Ordinary Shares
Medicinal Chemicals & Botanical Products
$1.02
-5.96% 1D
Market Cap $9.0M
TTM Revenue $19M
Forward P/E 2.4x
Beta / 30D Vol -0.06β · 35% Vol
Unified Composite Score
52.3 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 50.0 Mom 73.6
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.6%), weak momentum, RSI 25
RSI-14: 25.4 · SMA20: $1.12 · SMA50: $1.14

6-Pillar Scorecard Institutional Category Breakdown (AIFU 0 – 5 BON)

Columns: Metric · AIFU · BON
1. Valuation Multiples BON
Forward P/E 18.8x 2.4x
Trailing P/E 20.4x 2.4x
PEG Ratio N/M N/M
EV / Revenue 1.2x 0.5x
2. Growth & Scale BON
Revenue Growth (YoY) -24.0% +1.9%
Earnings Growth (YoY) -96.8% -41.0%
TTM Revenue (USD) $485M $19M
Market Cap $590.2M $9.0M
3. Profitability & Quality BON
Gross Margin 50.9% 22.1%
Operating Margin -220.0% -45.5%
Net Profit Margin 0.0% -60.4%
Return on Equity (ROE) -112.3% -21.8%
4. Balance Sheet & Cash Flow BON
Cash Generation (TTM) -$1.06B EBITDA -$7.3M EBITDA
Cash Flow Margin N/A -38.8% EBITDA Mgn
Net Cash / Leverage $25.31 Book/Sh · -112.3% ROE $8.18 Book/Sh · -21.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 142.0% (50th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BON
OpEx & R&D Intensity N/A 67.6% of Rev ($13M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Insurance Brokers Operator Specialty Chemicals Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: AIFU (4) vs BON (6)
Institutional Metric AIFU BON Criterion Row Edge
Market Capitalization
Scale
$590.2M $9.0M Larger Scale AIFU
Trailing P/E Ratio
Valuation
20.4x 2.4x Lower Multiple BON
Forward P/E Ratio
Valuation
18.8x 2.4x Lower Multiple BON
Revenue Growth (YoY)
Growth
-24.0% +1.9% Higher Growth BON
Operating Margin (TTM)
Profitability
-220.0% -45.5% Higher Margin BON
Net Profit Margin
Profitability
0.0% -60.4% Higher Margin AIFU
Return on Equity (ROE)
Capital Efficiency
-112.3% -21.8% Higher ROE BON
52-Week Range Position
Momentum
15% ($1–$60) 8% ($1–$2) Stronger Trend AIFU
Beta / 30D Volatility
Risk Regime
-7.07β · 88% Vol -0.06β · 35% Vol Lower Realized Risk BON
Unified Institutional Score
Composite Signal
58.5 / 100 (HOLD) 52.3 / 100 (HOLD) Higher Composite AIFU
Trailing 12M Revenue (USD)
Operating Scale
$485M $19M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
50.9% 22.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.2x EV/Rev N/M PEG · 0.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$1.06B EBITDA ($25.31 Book/Sh · -112.3% ROE) -$7.3M EBITDA ($8.18 Book/Sh · -21.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BON +3.33 pp
AIFU: -11.71% · BON: -8.38%
3M Horizon BON +11.86 pp
AIFU: -21.95% · BON: -10.09%
6M Horizon AIFU +372.23 pp
AIFU: +351.69% · BON: -20.54%
1Y Horizon AIFU +189.07 pp
AIFU: +143.3% · BON: -45.77%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AIFU vs BON. Trailing 12-month operating profitability (AIFU -220.0% vs BON -45.5%) and valuation multiples (AIFU 18.8x vs BON 2.4x Forward P/E) are benchmarked directly in Pillar 4 below.

AIFU ADR TTM Benchmark FX-Normalized USD
TTM Revenue$485M
Gross Margin50.9%
Op. Margin-220.0%
ROE / Fwd P/E-112.3% · 18.8x
BON ADR TTM Benchmark FX-Normalized USD
TTM Revenue$19M
Gross Margin22.1%
Op. Margin-45.5%
ROE / Fwd P/E-21.8% · 2.4x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
AIFU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 142.0%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact AIFU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BON UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
AIFU Moat Profile Cyclical / Execution-Driven Positioning
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $590.2M market capitalization and -220.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BON Moat Profile Cyclical / Execution-Driven Positioning
Specialty Chemicals Operator
Competes within the Specialty Chemicals value chain with $9.0M market capitalization and -45.5% operating margin.
OpEx & R&D Reinvestment 67.6% of Rev ($13M)
90D Engineering Disclosures 0 Published

Investor FAQ AIFU vs BON Key Questions & Quantitative Answers

As of Nov 17, 2026, Bon Natural Life Limited Class A (BON) is the stronger overall head-to-head candidate over AIFU Inc. Class A Ordinary Share (AIFU) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). AIFU carries a Unified Composite Score of 58.5/100 (HOLD) at $9.76 (18.8x Forward P/E, -220.0% operating margin), whereas BON carries 52.3/100 (HOLD) at $1.02 (2.4x Forward P/E, -45.5% operating margin). Composite vs. Pillar Nuance: While AIFU currently prints a higher short-term Unified Composite Score (58.5/100 HOLD vs. BON 52.3/100 HOLD), BON captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-45.5% vs. -220.0% operating margin) and revenue trajectory (+1.9% vs. -24.0% YoY). Technical & Structure Timing Caution: AIFU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.1); meanwhile BON is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BON leads the Growth & Scale pillar: AIFU posts -24.0% YoY revenue growth and -96.8% YoY earnings growth on $485M TTM revenue (50.9% gross margin, -220.0% operating margin), compared with BON at +1.9% YoY revenue growth and -41.0% YoY earnings growth on $19M TTM revenue (22.1% gross margin, -45.5% operating margin). On trailing 12-month operating scale, AIFU generates $485M in USD-normalized revenue versus $19M for BON. In operating R&D and SG&A reinvestment, AIFU deploys N/A (0 90-day corporate R&D disclosures) versus 67.6% of Rev ($13M) (0 disclosures) for BON.

BON screens cheaper on headline valuation multiples. AIFU trades at 18.8x Forward P/E, 20.4x Trailing P/E, N/M PEG, and 1.2x EV/Revenue (unreported EBITDA margin), whereas BON trades at 2.4x Forward P/E, 2.4x Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-38.8% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AIFU (-112.3% ROE) versus BON (-21.8% ROE) capital efficiency.

In options market volatility and institutional positioning, AIFU carries 142.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-7.07β · 88% Vol realized risk). By comparison, BON carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.06β · 35% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.